SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other...
Break of 14.13., Stop 12.78, Target 1 15.83 Target 2 Momentum
Holding well at 78.6% fibs. Closing above 8ema (orange line) will be a bullish move and a optimum entry. If wrong then I will be looking at the 50% fibs & 200ma line for a bounce entry.
Production resumed... oil flying Undervalued fundamentally. Cup & handle pattern apparently in play with golden crosses forming on daily and hourly timeframes currently.